I agree that this site is using cookies. You can find further informations here.
X
Brahmi, M.
~ 300  results:
Search for persons X
?
1

Improved nationwide survival of sarcoma patients with a net..:

Blay, J.Y. ; Penel, N. ; Valentin, T....
Annals of Oncology.  35 (2024)  4 - p. 351-363 , 2024
Link: https://doi.org/10.1016/..
 
?
2

55O IMADGIST: A randomized study of 6 vs 3 years of adjuvan..:

Le Cesne, A. ; Chabaud, S. ; Bouche, O....
ESMO Open.  9 (2024)  - p. 102445 , 2024
Link: https://doi.org/10.1016/..
 
?
3

63P Systemic therapy for KIT/PDGFRA wild-type GIST:

Dupont, M. ; Lamkhioued, M. ; Pissaloux, D...
ESMO Open.  9 (2024)  - p. 102453 , 2024
Link: https://doi.org/10.1016/..
 
?
4

52O Resistance to imatinib induced by treatment interruptio..:

Blay, J-Y. ; Devin, Q. ; Duffaud, F....
ESMO Open.  9 (2024)  - p. 102442 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Unraveling the Interplay of Karuna and Jnana: Mapping Empat..:

Brahmi, M ; Suresh, G ; Goyal, V..
British Journal of Multidisciplinary and Advanced Studies.  5 (2024)  4 - p. 1-20 , 2024
Link: https://doi.org/10.37745..
 
?
6

59MO COTESARC – A multicentre, phase I-II clinical trial ev..:

Dufresne, A. ; Brahmi, M. ; Cropet, C....
ESMO Open.  9 (2024)  - p. 102449 , 2024
Link: https://doi.org/10.1016/..
 
?
7

89P IMmunotherapy response associated clinical and biologic..:

Fazel, M. ; Varnier, R. ; Blay, J-Y..
ESMO Open.  9 (2024)  - p. 102478 , 2024
Link: https://doi.org/10.1016/..
 
?
8

VP3-2024: A randomized study of 6 vs 3 years of adjuvant im..:

Le Cesne, A. ; Schiffler, C. ; Bouche, O....
Annals of Oncology.  35 (2024)  6 - p. 576-577 , 2024
Link: https://doi.org/10.1016/..
 
?
9

64P Tertiary lymphoid structure and efficacy of doxorubicin..:

Grassi, M. ; Dufresne, A. ; Karanian, M....
ESMO Open.  8 (2023)  1 - p. 101101 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Staging of newly diagnosed Ewing sarcoma: Results of bone m..:

Guinot, A. ; Tabone-Eglinger, S. ; Isnardi, V....
European Journal of Cancer.  179 (2023)  - p. 56-64 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Bilan d'extension initial du sarcome d'Ewing : comparaison ..:

Isnardi, V. ; Guinot, A. ; Bahri, H....
Médecine Nucléaire.  47 (2023)  2 - p. 46 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Efficacy of immune checkpoint inhibitors in alveolar soft-p..:

Hindi, N. ; Razak, A. ; Rosenbaum, E....
ESMO Open.  8 (2023)  6 - p. 102045 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Natural history and treatment efficacy in an ambispective c..:

Dufresne, A. ; Pissaloux, D. ; Ngo, C....
ESMO Open.  8 (2023)  2 - p. 101202 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nat..:

Blay, JY ; Piperno-Neumann, S. ; Watson, S....
European Journal of Cancer.  192 (2023)  - p. 113262 , 2023
Link: https://doi.org/10.1016/..
 
?
15

66P Therapeutic opportunities in sarcomas and rare tumors: ..:

Vanacker, H. ; Brahmi, M. ; Cassier, P....
ESMO Open.  8 (2023)  1 - p. 101103 , 2023
Link: https://doi.org/10.1016/..
 
1-15